Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Stewart, A., Coker, E.A., Pölsterl, S., Georgiou, A., Minchom, A.R., Carreira, S., Cunningham, D., O'Brien, M.E., Raynaud, F.I., de Bono, J.S., et al. (2019). Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant Cancers. Molecular cancer therapeutics, Vol.18 (8), pp. 1396-1404.

Banerji, U., van Herpen, C.M., Saura, C., Thistlethwaite, F., Lord, S., Moreno, V., Macpherson, I.R., Boni, V., Rolfo, C., de Vries, E.G., et al. (2019). Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study. The lancet oncology, Vol.20 (8), pp. 1124-1135.

Banerji, U., Dean, E., Pérez-Fidalgo, J.A., Batist, G., Bedard, P.L., You, B., Westin, S.N., Kabos, P., Garrett, M.D., Tall, M., et al. (2017). A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers. Clinical cancer research, .  show abstract